Dorzolamide
Glaucoma · Rx
RxGlaucomaGlaucoma Cai Orange cap
| Strength | 2% |
|---|---|
| Typical quantity | 10 mL bottle (generic) |
| Cash cost / month | Low · ~$0-20 |
| Drug class | Topical carbonic anhydrase inhibitor |
| Mechanism of action | Inhibits carbonic anhydrase II in the ciliary epithelium, reducing bicarbonate and hence aqueous formation. ~15-20% IOP reduction. May improve ocular blood flow. |
| Indication / reason for use | Open-angle glaucoma and ocular hypertension; adjunct; useful in patients who cannot take beta-blockers. Also used in some cystoid macular edema / retinitis pigmentosa CME. |
| Usual adult dosing | 1 drop three times daily as monotherapy, twice daily as adjunct. |
| Preservative | BAK 0.0075% |
| Contact lenses | Remove lenses; reinsert after 15 minutes. |
| Common / important adverse effects | Marked stinging and bitter taste (very common), transient blur, punctate keratitis; corneal endothelial decompensation in eyes with low endothelial cell counts (Fuchs, prior graft); rare sulfonamide hypersensitivity systemically. |
| Contraindications & cautions | Severe renal impairment (CrCl <30); true sulfonamide allergy is a labelled contraindication; compromised corneal endothelium. |
| Pregnancy / lactation | Limited data; animal data show reduced fetal weight. Avoid where possible. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Trusopt |
| Practice notes | Check corneal status before prescribing to a Fuchs or post-graft patient, CAIs can tip a marginal endothelium into edema. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.